Drug name - Symjepi

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11141540 ADAMIS PHARMS CORP Syringe devices
Oct, 2036

(13 years from now)

Drugs and Companies using EPINEPHRINE ingredient

Market Authorisation Date: 15 June, 2017

Treatment: A method for administering a therapeutic dose of epinephrine

Dosage: SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
0.15MG/0.3ML (0.15MG/0.3ML) SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS Prescription
0.3MG/0.3ML (0.3MG/0.3ML) SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.

Other things you might be interested in